Back to Search Start Over

Osteoarticular Mycoses

Authors :
Maria N. Gamaletsou
Blandine Rammaert
Barry Brause
Marimelle A. Bueno
Sanjeet S. Dadwal
Michael W. Henry
Aspasia Katragkou
Dimitrios P. Kontoyiannis
Matthew W. McCarthy
Andy O. Miller
Brad Moriyama
Zoi Dorothea Pana
Ruta Petraitiene
Vidmantas Petraitis
Emmanuel Roilides
Jean-Pierre Sarkis
Maria Simitsopoulou
Nikolaos V. Sipsas
Saad J. Taj-Aldeen
Valérie Zeller
Olivier Lortholary
Thomas J. Walsh
Laiko General Hospital
University of Athens School of Medicine
Pharmacologie des anti-infectieux et antibiorésistance (PHAR2)
Université de Poitiers-Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre hospitalier universitaire de Poitiers (CHU Poitiers)
Université de Poitiers - Faculté de Médecine et de Pharmacie
Université de Poitiers
Hospital for Special Surgery
Far Eastern Federal University (FEFU)
City of Hope National Medical Center
Nationwide Children's Hospital
The Ohio State University School of Medicine
The University of Texas M.D. Anderson Cancer Center [Houston]
Weill Medical College of Cornell University [New York]
New York Presbyterian Hospital
NIH Clinical Center, Bethesda, Maryland
Hippokration General Hospital
Aristotle University of Thessaloniki
Hamad Medical Corporation [Doha, Qatar]
Groupe Hospitalier Diaconesses Croix Saint-Simon
CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Génomique évolutive, modélisation et santé (GEMS)
Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)
Center for Innovative Therapeutics and Diagnostics, Richmond, Virginia
Source :
Clinical Microbiology Reviews, Clinical Microbiology Reviews, 2022, ⟨10.1128/cmr.00086-19⟩
Publication Year :
2022
Publisher :
American Society for Microbiology, 2022.

Abstract

Osteoarticular mycoses are chronic debilitating infections that require extended courses of antifungal therapy and may warrant expert surgical intervention. As there has been no comprehensive review of these diseases, the International Consortium for Osteoarticular Mycoses prepared a definitive treatise for this important class of infections. Among the etiologies of osteoarticular mycoses are Candida spp., Aspergillus spp., Mucorales, dematiaceous fungi, non-Aspergillus hyaline molds, and endemic mycoses, including those caused by Histoplasma capsulatum, Blastomyces dermatitidis, and Coccidioides species. This review analyzes the history, epidemiology, pathogenesis, clinical manifestations, diagnostic approaches, inflammatory biomarkers, diagnostic imaging modalities, treatments, and outcomes of osteomyelitis and septic arthritis caused by these organisms. Candida osteomyelitis and Candida arthritis are associated with greater events of hematogenous dissemination than those of most other osteoarticular mycoses. Traumatic inoculation is more commonly associated with osteoarticular mycoses caused by Aspergillus and non-Aspergillus molds. Synovial fluid cultures are highly sensitive in the detection of Candida and Aspergillus arthritis. Relapsed infection, particularly in Candida arthritis, may develop in relation to an inadequate duration of therapy. Overall mortality reflects survival from disseminated infection and underlying host factors.

Details

ISSN :
10986618 and 08938512
Volume :
35
Database :
OpenAIRE
Journal :
Clinical Microbiology Reviews
Accession number :
edsair.doi.dedup.....9c252f0b7c1c9d4361860c7eba6b44cd
Full Text :
https://doi.org/10.1128/cmr.00086-19